Mercado-Gutiérrez MN, Villa-Manzano AI, Yáñez-Ortega R, Duarte-Esparza AE, Estrella-Mercado M, Robles-Cruz JA

Language: Spanish
References: 10
Page: 6-10
PDF size: 220.49 Kb.

ABSTRACT

Introduction: SARS-CoV-2 (COVID-19) infection is a systemic disease that can leave sequelae that could affect the patient's long-term work capacity, however this effect has not been studied. Objective: to determine the risk of work disability after COVID-19 infection. Material and methods: cohort study. A non-exposed (without COVID) and exposed (with COVID) group were compared each with 204 patients, 1-year follow-up. Comparing work incapacity (event). Descriptive statistics: frequencies, percentages with their respective 95% confidence interval; quantitative variables: mean and standard deviation; analytical statistics: Student's t for related samples, McNemar χ² and relative risk statistical significance: p < 0.05, which is performed in the SPSS v. 2021 program. Results: when comparing the group without COVID vs the group with COVID, the following was obtained: incidence of work disability 21% (43) vs 33% (67), p = 0.01 with a RR 1.32 (1.09-1.60); subsequent disabilities 7.4% (15) vs 10.8% (22), p = 0.30, RR 1.21 (0.91-1.61); number of initial disabilities in each period (expressed as mean and standard deviation) 0.25 ± 0.52 vs 0.52 ± 1.02, p = 0.001; number of days of subsequent disabilities 0.11 ± 0.44 vs 0.19 ± 0.60, p = 0.136; number of days of total disability 1.73 ± 4.8 vs 3.29 ± 7.81, p = 0.015. Conclusions: there is a higher risk of work disability after infection by coronavirus SARS-CoV-2 (COVID-19).

REFERENCES

1. Barroso López KR, Peñasco García P, Soria López CI, Pérez Fernández MC, Gómez Cruz JG, González Silva Y. Características y evolución de los pacientes COVID-19 en un centro de salud urbano al inicio de la pandemia. Aten Primaria. 2021;53(2):101957.

2. Mariños Sánchez E, Espino Alvarado P, Rodríguez L, Barreto Acevedo E. Manifestaciones neurológicas asociadas a COVID-19 en el Hospital Edgardo Rebagliati Martins, Perú. Rev Neuropsiquiatr. 2021;83(4):243-256. doi: 10.20453/rnp.v83i4.3890.

3. Padilla Benítez T, Rojas AL, Munive Báez L, Monsiváis Orozco AC, Dionicio Avendaño AR, Corona Villalobos CA, et al. Manifestaciones clínicas de la COVID-19. Rev Latin Infect Pediatr. 2020;33(s1):10-32. doi: 10.35366/96668.

4. Atzrodt CL, Maknojia I, McCarthy RDP, Oldfield TM, Po J, Ta KTL, et al. A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2. FEBS J. 2020;287(17):3633-3650. doi: 10.1111/febs.15375.

5. Disser NP, De Micheli AJ, Schonk MM, Konnaris MA, Piacentini AN, Edon DL, et al. Musculoskeletal consequences of COVID-19. J Bone Joint Surg Am. 2020;102(14):1197-1204. doi: 10.2106/JBJS.20.00847.

6. Karadas O, Oztürk B, Sonkaya AR. A prospective clinical study of detailed neurological manifestations in patients with COVID-19. Neurol Sci. 2020;41(8):1991-1995. doi: 10.1007/s10072-020-04547-7.

7. Vicente Pardo JM, López-Guillén García A. El síndrome post COVID, incapacidad temporal laboral y prevención. Prevencionar.com [Internet]. 2021 [citado el 23 de noviembre de 2021]. Disponible en: https://prevencionar.com/2021/04/15/el-sindrome-post-covid-incapacidad-temporal-laboral-y-prevencion/

8. Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.

9. Kemp HI, Corner E, Colvin LA. Chronic pain after COVID-19: implications for rehabilitation. Br J Anaesth. 2020;125(4):436-440. doi: 10.1016/j.bja.2020.05.021.

10. Stewart-Patterson C, Bourgeois R, Martin DW. The importance of keeping patients with post-acute sequelae of SARS-CoV-2 infection (long COVID) engaged in work. Am Fam Physician. 2021;103(12):710.